HIMS is trading at $27.07 (+5.5%) as of May 8, 2026, rebounding sharply from a 4.6% decline in the prior session triggered by concerns over Amazon's entry into the telehealth weight-loss market.
- Investor sentiment is stabilizing ahead of Monday's Q1 earnings report, which is expected to provide critical clarity on the company's competitive positioning and subscription growth.
- Broader market strength is supporting the recovery, with the NASDAQ up 1.41% on strong jobs data, though options pricing indicates elevated volatility with an expected move of ±$0.77 (2.99%).